The research progress of Th17/Treg imbalance in pathogenesis of pulmonary disease
ZHANG Yi1,2 ZHANG Lanying1 OUYANG Yao1
1.The First Department of Respiratory Medicine, Affiliated Hospital of Zunyi Medical College, Guizhou Province, Zunyi 563003, China;
2.Department of Internal Medicine, the Second People's Hospital of Zunyi, Guizhou Province, Zunyi 563003, China
Abstract：T helper 17 cells (Th17) with pro-inflammatory activity and regulatory T cells (Treg) cells that maintain immune tolerance are important immune cells in humans. They are closely related in differentiation and functional constraints to each other, and there is a dynamic balance. Imbalance between the two can lead to autoimmune diseases, tumors, persistent infection diseases. In recent years, with the study of the common diseases of the respiratory system deeply, of Th17 cells and Treg cells were found to be associated with more lung disease pathogenesis, immune imbalance of Th17/Treg cells in patients with chronic obstructive pulmonary disease, lung cancer, pulmonary sarcoidosis and asthma among the adjustment mechanism. This article describes the progress of Th17 cells, Treg cells and Th17/Treg imbalance in lung related diseases.
[1] Kleinewietfeld M，Hafler DA. The plasticity of human Treg and Th17 cells and its role inautoimmunity [J]. Semin Immunol，2013，25（4）：305-312.
[2] Costantino CM，Baecher-Allan CM，Hafler DA. Human regulatory T cells and autoimmunity [J]. Eur J Immunol，2008， 38（4）：921-924.
[3] Zhou L，Chong MM，Littman DR. Plasticity of CD4+T cell lineage differentiation [J]. Immunity，2009，30（5）：646-55.
[4] Hemdan NY，Birkenmeier G，Wichmann G，et al. Interleukin-17-producing T helper cells in autoimmunity [J]. Autoimmun Rev，2010，9（11）：785.
[5] Hirota K，Martin B，Veldhoen M. Development，regulation and functional capacities of Th17 cells [J]. Semin Immunopathol，2010，32（1）：3-16.
[6] Arellanoorden E，Caleroacuña C，Morenomata N，et al. Cigarette Smoke Decreases the Maturation of Lung Myeloid Dendritic Cells [J]. PloS One，2016，11（4）：e0152 737.
[7] Song X，Gao H，Qian Y. Th17 differentiation and their pro-infammation function [J]. Adv Exp Med Biol，2014， 841： 99-151
[8] Kimura A，Kishimoto T. IL-6：regulator of Treg/Th17 balance [J]. Eur J Immunol，2010，40（7）：1830-1835.
[9] Vernal R，Garcia-Sanz JA. Th17 and Treg cells，two new lymphocyte subpopulations with a key role in the immune response against infection [J]. Infect Disord Drug Targets，2008，8（4）：207-20.
[10] Garín MI，Chu CC，Golshayan D，et al. Galectin-1：a key effector of regulation mediated by CD4+CD25+ T cells [J]. Blood，2007，109（5）：2058.
[11] Cao X，Cai SF，Fehniger TA，et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance [J]. Immunity，2007，27（4）：635.
[12] Bettelli E，Dastrange M，Oukka M. Foxp3 interacts with nuclear factor of activated T cellsand NF·kappa B to repress cytokine gene expression and effector functions of T helper cells [J]. Proc Natl Acad Sci USA，2005，102（14）：5138-5143.
[13] Jadidiniaragh F，Mirshafiey A. The deviated balance between regulatory T cell and Th17 in autoimmunity [J]. Immunopharmacol Immunotoxicol，2012，34（5）：727-39.
[14] Kimura A，Kishimoto T. IL-6：Regulator of Treg/Th17 balance [J]. Eur J Immunol，2010，40（7）：1830.
[15] Xu LL，Kitani A，Fuss I，et al. Cutting Edge：Regulatory T cells induce CD4+CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta [J]. J Immunol，2007，178（11）：6725-6729.
[16] Vogelmeier CF，Criner GJ，Martinez FJ，et al. Global strategy for the diagnosis，management，and prevention of chronic obstructive lung disease 2017 report [J]. Am J Respir Crit Care Med，2017，195（5）：557.
[17] Zhang J，Chu S，Zhong X，et al. Increased expression of CD4+IL-17+cells in the lung tissue of patients with stable chronic obstructive pulmonary disease（COPD）and smokers [J]. Int Immunopharmacol，2013，15（1）：58-66.
[18] 张建全.Th17细胞及相关因子在稳定期慢性阻塞性肺疾病患者肺部的表达及意义[D].南宁：广西医科大学，2010.
[19] Vargasrojas MI，Ramírezvenegas A，Limóncamacho L，et al. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease [J]. Respir Med， 2011，105（11）：1648.
[20] 李泽伦.慢性阻塞性肺疾病患者急性加重期及稳定期血清Th17/Treg相关细胞因子与肺功能、生活质量（CAT评分）的相关性分析[D].广州：广州医科大学，2015.
[21] Maniati E，Hagemann T. IL-17 mediates resistance to anti-VEGF therapy [J]. Nat Med，2013，19（9）：1092.
[22] Smyth LJ，Starkey C，Vestbo J，et al. CD4-regulatory cells in COPD patients [J]. Chest，2007，132（1）：156-163.
[23] 张婧.慢性阻塞性肺疾病小鼠体内CD83、Th17/Treg细胞的变化及意义[D].遵义：遵义医学院，2016.
[24] 章颖妹，严青，刘辉，等. Treg在慢性阻塞性肺疾病患者外周血及肺组织中的表达[J].安徽医科大学学报，2015， （5）：679-682
[25] Wang H，Peng W，Weng Y，et al. Imbalance of Th17/Treg cells in mice with chronic cigarette smoke exposure [J]. Int Immunopharmacol，2012，14（4）：504-512.
[26] Isajevs S，Taivans I，Strazda G，et al. Decreased FOXP3 expression in small airways of smokers with COPD [J]. Eur Respir J，2009，33（1）：61-67.
[27] Roos-Engstrand E，Pourazar J，Behndig AF，et al. Expansion of CD4+CD25+helper T cells without regulatory function in smoking and COPD [J]. Respir Res，2011，12（1）：1-8.
[28] Li XN，Pan X，Qiu D. Imbalances of Th17 and Treg cells and their respective cytokines in COPD patients by disease stage [J]. Int J Clin Exp Med，2014，7（12）：5324.
[29] Jin Y，Wan Y，Chen G，et al. Treg/IL-17 ratio and Treg differentiation in patients with COPD [J]. PLoS One，2014， 9（10）：e111 044.
[30] Wang H，Ying H，Wang S，et al. Imbalance of peripheral blood Th17 and Treg responses in patients with chronic obstructive pulmonary disease [J]. Clin Respir J，2014，9（3）：330-341.
[31] Zhao L，Yang J，Wang HP，et al. Imbalance in the Th17/Treg and cytokine environment in peripheral blood of patients with adenocarcinoma and squamous cell carcinoma [J]. Med Oncol，2013，30（1）：461.
[32] Takahashi H，Numasaki M，Lotze MT，et al. Interleukin－17 enhances bFGF－，HGF－and VEGF－induced growth of vascular endothelial cells [J]. Immunol Lett，2005，98（2）：189-193.
[33] 何燕超，施劲东，梅周芳，等.非小细胞肺癌患者外周血Th17和Treg表达的意义[J].复旦学报：医学版，2015， 42（3）：362-367.
[34] Duan MC，Han W，Jin PW，et al. Disturbed Th17/Treg balance in patients with non-small cell lung cancer [J]. Inflammation，2015，38（6）：2156-2165.
[35] Kaiser Y，Lepzien R，Kullberg S，et al. Expanded lung T-bet+RORγT+CD4+T-cells in sarcoidosis patients with a favourable disease phenotype [J]. Eur Respir J，2016， 48（2）：484.
[36] 黄慧.结节病患者Th17细胞和Treg细胞的表达水平及糖皮质激素治疗干预的影响[D].北京：中国医学科学院北京协和医学院，2011.
[37] Idali F，Wahlström J，Müller-Suur C，et al. Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis [J]. Clin Exp Immunol，2008，152（1）：127.
[38] Miyara M，Amoura Z，Parizo C，et a1. The immune paradox of sarcoidosis and regulatory Tcells [J]. J Exp Med，2006，203（2）：359-370.
[39] 翁跃颂，王华英，吕定丰，等.结节病患者辅助性T细胞17和调节性T细胞与疾病活动的关系[J].浙江大学学报：医学版，2015，44（2）：154-161.
[40] 黄燕，陆聪哲，王彩彩，等.结节病患者外周血Th17细胞表达及临床意义[J].中国呼吸与危重监护杂志，2013， 12（2）：173-176.
[41] 王君丽，徐彦飞，李小莉，等. Th17/Treg细胞在支气管哮喘患者外周血中的表达[J].中国医学创新，2016，13（24）：117-119.
[42] 田祖慧，左凤琼，张魏.哮喘患儿诱导痰中T细胞亚群和细胞因子的变化及意义[J].海南医学院学报，2016， 22（1）：72-74.
[43] Zijlstra GJ，Ten Hacken NH，Hoffmann RF，et al. Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells [J]. Eur Respir J，2012，39（2）：439-445.
[44] Hou X，Wan H，Ai X，et al. Histone deacetylase inhibitor regulates the balance of Th17/Treg in allergic asthma [J]. Clin Respir J，2016，10（3）：371.
[45] Qin SM，Shi HZ，Qin XJ，et al. CD4+CD25+ T lymphocytes in peripheral blood from patients with asthma [J]. Zhonghua Jie He He Hu Xi Za Zhi，2006，29（4）：252.
[46] 刘敏，马骁，张海伶.Th17/Treg相关因子在哮喘小鼠中的表达变化及其意义[J].生物医学工程与临床，2016（5）：529-533.
2017, Vol. 14 
京公网安备 11010502046598号